BAYER RAPIDPOINT 405 SYSTEM

System, Hemoglobin, Automated

BAYER DIAGNOSTICS CORP.

The following data is part of a premarket notification filed by Bayer Diagnostics Corp. with the FDA for Bayer Rapidpoint 405 System.

Pre-market Notification Details

Device IDK020616
510k NumberK020616
Device Name:BAYER RAPIDPOINT 405 SYSTEM
ClassificationSystem, Hemoglobin, Automated
Applicant BAYER DIAGNOSTICS CORP. 63 NORTH ST. Medfield,  MA  02052
ContactThomas F Flynn
CorrespondentThomas F Flynn
BAYER DIAGNOSTICS CORP. 63 NORTH ST. Medfield,  MA  02052
Product CodeGKR  
CFR Regulation Number864.5620 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-02-25
Decision Date2002-07-17
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414947549 K020616 000
00630414947532 K020616 000
00630414947525 K020616 000
00630414553610 K020616 000
00630414553603 K020616 000
00630414477855 K020616 000
00630414477848 K020616 000
00630414477831 K020616 000
00630414477824 K020616 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.